Glaxosmithkline | GSK - 营业利润

金融业

GBP

GBP 82.34B

现金及等价物

GBP 3.3B

GBP 3.47B

GBP 23.59B

GBP 28.82B

GBP 17.75B

股息收益率

GBP 4.47

GBP 2.3B

GBP 4.75B

GBP 69.4K

EPS每股收益

GBP 0.62

股本和储备

GBP 22.06B

GBP 8.75B

债务利息支出

GBP 177.95M

GBP 26M

GBP 19.82B

GBP 101.72B

GBP 846.06M

GBP 9.17B

GBP 2.3B

普通股股本

GBP 4.08B

11.66

GBP 2.46B

GBP 10.09B

销售和管理费用

GBP 3.56B

GBP 6.12B

贸易债权人

GBP 20.72B

应收帐款人

GBP 10.45B

	营业利润	更改		日
AbbVie	USD 4.73B		1.08B	2026-03
Amgen	USD 3.83B		130M	2026-03
AstraZeneca	USD 7.11B		4.14B	2026-03
Aurora Cannabis	CAD -35.79M		19.88M	2025-12
Bausch Health Companies	USD 489M		230M	2026-03
Bristol-Myers Squibb	USD 4.2B		562M	2025-12
Canopy Growth	CAD -12.66M		1.64M	2025-12
Corcept Therapeutics	USD -49.6M		54.09M	2026-03
Drreddys Laboratories	INR 14.33B		2.51B	2025-12
Eli Lilly	USD 9.78B		792M	2026-03
GlaxoSmithKline	GBP 2.29B		856M	2026-03
Glaxosmithkline	GBP 2.3B		1.46B	2025-12
J&J	USD 6.62B		1.03B	2026-03
Merck	USD -1.88B		8.12B	2026-03
Novartis	USD 4.24B		171M	2026-03
Pacira	USD 4.62M		1.43M	2026-03
Perrigo	USD 33.6M		50.8M	2026-03
Pfizer	USD 4.99B		340M	2026-03
Phibro Animal Health	USD 54.99M		2.36M	2025-12
Prestige Brands	USD 75.49M		7M	2026-03
Roche Holding	CHF 9.56B		3.8B	2025-12
Sanofi	EUR 1.94B		239M	2026-03
Supernus Pharmaceuticals	USD -35.25M		49.07M	2026-03
Takeda	JPY -13.62B		182.44B	2026-03
Teva Pharmaceutical Industries	USD 758M		271M	2026-03
Zoetis	USD 865M		30M	2026-03